Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a
human optimization sciences company with an emphasis on ketamine and
psychedelic medicine, on Monday announced the appointment of Dr. Bill
Wilkerson, LL.D. (Hon), an 8-time award-winning pioneer in workplace mental
health, to its board of directors. In addition, the company reported the
resignation of Mr. Joe Perino from its board of directors. “We are thrilled to
welcome Dr. Wilkerson to our board of directors. I look forward to working with
him on a personal level as his decades of thought leadership in mental health
and extensive global network will be vital to guiding our strategic initiatives
and driving operational growth. As we forge a path forward, Dr. Wilkerson’s
counsel and expertise will strengthen our mission-critical solutions to better
serve our patients along with our employees and shareholders. I am a strong
believer that the best processes have a people-centric vision front of mind.
Dr. Wilkerson’s years of steadfast diligence and empathy in this space are a
valued contribution to our efforts overall,” Champignon Brands CEO Dr. Roger
McIntyre stated in the news release.
To view the full press release, visit http://ibn.fm/YBhwy
About Champignon Brands Inc.
Champignon Brands is focused on the formulation and
manufacturing of novel ketamine, anaesthetics and adaptogenic delivery
platforms for the nutraceutical and psychedelic medicine while being supported
by a leading psychedelics medicines clinic platform. The Company is pursuing
the development and commercialization of rapid onset treatments capable of
improving health outcomes, such as depression and post-traumatic stress
disorder (“PTSD”), as well as substance and alcohol use disorders. Under a
collaborative research agreement with the University of Miami’s Miller School
of Medicine, the Company is conducting preclinical studies and eventual human
clinical trials, with the objective of demonstrating safety and efficacy of the
combination of psilocybin and cannabidiol in treating mTBI with PTSD or
stand-alone PTSD. Champignon continues to be inspired by sustainability, as its
medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For
more information, visit the Company’s website at www.ChampignonBrands.com.
NOTE TO INVESTORS: The latest news and updates
relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment